These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23705632)

  • 1. Developmental neuroplasticity and the origin of neurodegenerative diseases.
    Schaefers AT; Teuchert-Noodt G
    World J Biol Psychiatry; 2016 Dec; 17(8):587-599. PubMed ID: 23705632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Plasticity of the Hippocampus in Neurodegenerative Diseases.
    Weerasinghe-Mudiyanselage PDE; Ang MJ; Kang S; Kim JS; Moon C
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroplasticity, the aging brain, and Alzheimer's disease.
    Walsh TJ; Opello KD
    Neurotoxicology; 1992; 13(1):101-10. PubMed ID: 1508410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting neuroplasticity in patients with neurodegenerative diseases using brain stimulation techniques.
    Yuan TF; Li WG; Zhang C; Wei H; Sun S; Xu NJ; Liu J; Xu TL
    Transl Neurodegener; 2020 Dec; 9(1):44. PubMed ID: 33280613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease-like pathology.
    Stefanova NA; Maksimova KY; Kiseleva E; Rudnitskaya EA; Muraleva NA; Kolosova NG
    J Pineal Res; 2015 Sep; 59(2):163-77. PubMed ID: 25988948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hippocampus in aging and disease: From plasticity to vulnerability.
    Bartsch T; Wulff P
    Neuroscience; 2015 Nov; 309():1-16. PubMed ID: 26241337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-beta, tau protein, and oxidative changes as a physiological compensatory mechanism to maintain CNS plasticity under Alzheimer's disease and other neurodegenerative conditions.
    Koudinov A; Kezlya E; Koudinova N; Berezov T
    J Alzheimers Dis; 2009; 18(2):381-400. PubMed ID: 19749430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological approaches to cerebral aging and neuroplasticity.
    Jellinger KA; Attems J
    Dialogues Clin Neurosci; 2013 Mar; 15(1):29-43. PubMed ID: 23576887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroplasticity: main mechanisms and their clinical significance].
    Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(4):4-8. PubMed ID: 19491802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subfield-specific increase in brain growth protein in postmortem hippocampus of Alzheimer's patients.
    Rekart JL; Quinn B; Mesulam MM; Routtenberg A
    Neuroscience; 2004; 126(3):579-84. PubMed ID: 15183507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of obesity on neurodegenerative diseases.
    Mazon JN; de Mello AH; Ferreira GK; Rezin GT
    Life Sci; 2017 Aug; 182():22-28. PubMed ID: 28583368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization.
    Arendt T
    Neuroscience; 2001; 102(4):723-65. PubMed ID: 11182240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compensatory mechanisms to heal neuroplasticity impairment under Alzheiemer's disease neurodegeneration. I: The role of amyloid beta and its' precursor protein].
    Kudinov AR; Kudinova NV; Kezlia EV; Kozyrev KM; Medvedev AE; Berezov TT
    Biomed Khim; 2012; 58(4):385-99. PubMed ID: 23413683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
    Chen J; Wang ZF
    Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and hippocampal dysfunction: Disentangling peripheral and brain causes from consequences.
    Grillo CA; Woodruff JL; Macht VA; Reagan LP
    Exp Neurol; 2019 Aug; 318():71-77. PubMed ID: 31028829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.
    Mattson MP; Arumugam TV
    Cell Metab; 2018 Jun; 27(6):1176-1199. PubMed ID: 29874566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroplasticity in Alzheimer's disease.
    Teter B; Ashford JW
    J Neurosci Res; 2002 Nov; 70(3):402-37. PubMed ID: 12391603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral biomarkers in exercise-induced neuroplasticity in Parkinson's disease.
    Mougeot JL; Hirsch MA; Stevens CB; Mougeot F
    Oral Dis; 2016 Nov; 22(8):745-753. PubMed ID: 26878123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
    Koutsilieri E; Riederer P
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.